A multi-center, randomized, double-blinded, parallel, placebo-controlled study to assess the efficacy and safety of Shenqisuxin granule in complex coronary artery disease after PCI: Study protocol
Wu, Xiaoping, Yan, Mingyu, Pang, Xingxue, Wu, Hui, Hu, Zhigeng, Xiao, Rui, Pan, Jianlue, Li, Ying, Shi, Shengnan, Deng, Yanping, Li, Jiaxi, Wang, Peili, Chen, Keji
Published in Frontiers in cardiovascular medicine (12.09.2022)
Published in Frontiers in cardiovascular medicine (12.09.2022)
Get full text
Journal Article